Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis.
D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, Natale A, Hunter RJ, Schilling RJ, Miyazaki S, Tada H, Aonuma K, Yenn-Jiang L, Tao H, Ma C, Packer D, Hammill S, Gaita F. D'Ascenzo F, et al. Among authors: corleto a. Int J Cardiol. 2013 Sep 1;167(5):1984-9. doi: 10.1016/j.ijcard.2012.05.008. Epub 2012 May 22. Int J Cardiol. 2013. PMID: 22626840 Free article.
Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation.
Caponi D, Corleto A, Scaglione M, Blandino A, Biasco L, Cristoforetti Y, Cerrato N, Toso E, Morello M, Gaita F. Caponi D, et al. Among authors: corleto a. Europace. 2010 Aug;12(8):1098-104. doi: 10.1093/europace/euq107. Epub 2010 Apr 17. Europace. 2010. PMID: 20400766 Clinical Trial.
Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study.
Bianco M, Gravinese C, Cerrato E, Nuñez-Gil I, Destefanis P, Luciano A, Biscaglia S, Quadri G, Tizzani E, Corleto A, Giolitto S, Lo Savio L, Campo G, Varbella F, Pozzi R. Bianco M, et al. Among authors: corleto a. Minerva Cardioangiol. 2019 Apr;67(2):94-101. doi: 10.23736/S0026-4725.19.04787-X. Epub 2019 Mar 18. Minerva Cardioangiol. 2019. PMID: 30895761
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.
Gargiulo P, Basile C, Galasso G, Bellino M, D'Elia D, Patti G, Bosco M, Prinetti M, Andò G, Campanella F, Taverna G, Calabrò P, Cesaro A, Fimiani F, Catalano A, Varbella F, Corleto A, Barillà F, Muscoli S, Musumeci G, Delnevo F, Giallauria F, Napoli R, Porto I, Polimeni A, Quarta R, Maloberti A, Merlini PA, De Luca L, Casu G, Brunetti ND, Crisci M, Paloscia L, Bilato C, Indolfi C, Marzano F, Fontanarosa S, Buonocore D, Parlati ALM, Nardi E, Prastaro M, Soricelli A, Salvatore M, Paolillo S, Perrone-Filardi P; AT-TARGET-IT Investigators. Gargiulo P, et al. Among authors: corleto a. Eur J Prev Cardiol. 2024 May 24:zwae170. doi: 10.1093/eurjpc/zwae170. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38788773
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT).
Gargiulo P, Basile C, Cesaro A, Marzano F, Buonocore D, Asile G, Abbate V, Vicidomini F, Paolillo S, Spaccarotella CAM, Catalano A, Spirito G, Merlini PA, Maloberti A, Iannuzzo G, Ciccone MM, Zito AP, Paloscia L, D'Alleva A, Varbella F, Corleto A, Brunetti ND, Corbo MD, Calabrò P, Indolfi C, Perrone-Filardi P. Gargiulo P, et al. Among authors: corleto a. Atherosclerosis. 2023 Feb;366:32-39. doi: 10.1016/j.atherosclerosis.2023.01.001. Epub 2023 Jan 13. Atherosclerosis. 2023. PMID: 36696749 Free article.